- Home
- LUNG vs OSUR Comparison
LUNG vs OSUR Comparison
Compare LUNG & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- OSUR
- Stock Information
- Founded
- LUNG 1995
- OSUR 2000
- Country
- LUNG United States
- OSUR United States
- Employees
- LUNG N/A
- OSUR N/A
- Industry
- LUNG Industrial Specialties
- OSUR Medical/Dental Instruments
- Sector
- LUNG Health Care
- OSUR Health Care
- Exchange
- LUNG Nasdaq
- OSUR Nasdaq
- Market Cap
- LUNG 65.6M
- OSUR 229.7M
- IPO Year
- LUNG 2020
- OSUR 1986
- Fundamental
- Price
- LUNG $1.60
- OSUR $3.30
- Analyst Decision
- LUNG Buy
- OSUR Hold
- Analyst Count
- LUNG 7
- OSUR 1
- Target Price
- LUNG $7.66
- OSUR $3.00
- AVG Volume (30 Days)
- LUNG 467.3K
- OSUR 584.9K
- Earning Date
- LUNG 10-29-2025
- OSUR 11-05-2025
- Dividend Yield
- LUNG N/A
- OSUR N/A
- EPS Growth
- LUNG N/A
- OSUR N/A
- EPS
- LUNG N/A
- OSUR N/A
- Revenue
- LUNG $90,549,000.00
- OSUR $138,533,000.00
- Revenue This Year
- LUNG $10.30
- OSUR N/A
- Revenue Next Year
- LUNG $14.72
- OSUR $5.35
- P/E Ratio
- LUNG N/A
- OSUR N/A
- Revenue Growth
- LUNG 18.24
- OSUR N/A
- 52 Week Low
- LUNG $1.47
- OSUR $2.36
- 52 Week High
- LUNG $9.37
- OSUR $4.60
- Technical
- Relative Strength Index (RSI)
- LUNG 40.86
- OSUR 56.29
- Support Level
- LUNG $1.54
- OSUR $3.16
- Resistance Level
- LUNG $1.63
- OSUR $3.40
- Average True Range (ATR)
- LUNG 0.12
- OSUR 0.12
- MACD
- LUNG 0.02
- OSUR -0.00
- Stochastic Oscillator
- LUNG 19.35
- OSUR 52.94
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.